NBY Competitors & Alternatives
Compare NovaBay Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
NBY
Main Stock$1.95
Tradestie Score
43
Market Cap
$8.23M
Revenue Growth
-0.8%
Analyst Upside
-56.4%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.27
|
$114.01M | - | 44 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$28.67
|
$110.20M | - | 42 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$4.94
|
$71.69M | - | 45 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$11.27
|
$71.32M | - | 31 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$9.72
|
$67.94M | - | 55 | Compare |
|
SINT
SiNtx Technologies, Inc. Common Stock
|
$1.66
|
$11.23M | - | 40 | Compare |
|
SNGX
Soligenix, Inc. Common Stock
|
$0.39
|
$10.38M | - | 36 | Compare |
|
OGEN
Oragenics Inc.
|
$0.55
|
$5.86M | - | 44 | Compare |
|
CFOR
CFOR
|
- | - | - | - | Compare |
|
GHSI
GHSI
|
- | - | - | - | Compare |
More NBY Analysis
Data updated: Aug 09, 2026 | Industry: Biotechnology (SIC 2834)
238 stocks in this industry